Journal of Mid-Life Health (Jan 2020)

A study of matrix metalloproteinase-2 and interleukin-18 in preinvasive and invasive lesions of cancer cervix

  • Shuchi Shukla,
  • Sabuhi Qureshi,
  • Uma Singh,
  • Sanjay Khattri

DOI
https://doi.org/10.4103/jmh.JMH_87_19
Journal volume & issue
Vol. 11, no. 4
pp. 236 – 239

Abstract

Read online

Introduction: Human Papilloma-Virus infection is the major event for cervical carcinogenesis, whereas host physiological changes may confer individual susceptibility and prognosis. So here, we aimed to compare serum levels of matrix metalloproteinase-2 (MMP-2) and interleukin-18 (IL-18) between cervical cancer patients and healthy controls. Materials and Methods: In the present study, we enrolled 168 subjects (10 CIN I, 10 CIN II, 10 CIN III, and 54 invasive cervical cancers with 84 age-matched healthy controls). Serum levels were estimated by enzyme-linked immunosorbent assay. Results and Discussion: The levels of serum MMP-2 showed a characteristic pattern of increasing trend with statistically significant P value on comparing pre-invasive lesions and cervical cancer versus healthy controls. However, IL-18 levels showed a decreasing trend in serum levels of controls versus cases with a statistically significant P value (P < 0.05). Conclusion: MMP-2 accentuates tissue damage and controls many interleukins secretion, which leads invasion and malignancy. Increased levels of MMP-2 and decreased circulating levels of IL-18 were found in cases. Hence, we raise an issue to study MMP-2 and IL-18 further for their diagnostic and prognostic marker role.

Keywords